Men's Wearhouse

Latest Investing News

Shareholders of Men's Wearhouse, Inc. (NYSE: MW) looking to boost their income beyond the stock’s 1.4% annualized dividend yield can sell the January 2015 covered call at the $57.50 strike and collect the premium based on the $2.10 bid, which annualizes to an additional 9.1% rate of return against the current stock price (at Stock Options read »

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Lockheed Martin Corp. (NYSE: LMT) were yielding above the 3% mark based on its quarterly dividend (annualized to $6.00), with the stock changing hands as low as $199.43 on the day. Dividends are particularly important for investors to consider, read »

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of East West Bancorp, Inc (NASD: EWBC) were yielding above the 2% mark based on its quarterly dividend (annualized to $0.80), with the stock changing hands as low as $39.89 on the day. Dividends are particularly important for investors to consider, read »

In trading on Tuesday, shares of Cenovus Energy Inc. (Toronto: CVE) were yielding above the 5% mark based on its quarterly dividend (annualized to $1.0648), with the stock changing hands as low as $21.23 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a read »

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Broadridge Financial Solutions (NYSE: BR) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.08), with the stock changing hands as low as $53.85 on the day. Dividends are particularly important for investors to read »

When hedge fund manager “titans” think alike, investors are wise to pay attention. At Holdings Channel, we have reviewed 3,990 13F filings for the 12/31/2014 reporting period, and noticed that Valeant Pharmaceuticals International Inc (NYSE: VRX) was held by 9 of the particular managers we have flagged as “titans” most widely followed by read »

At Holdings Channel, we have reviewed 3,990 13F filings for the 12/31/2014 reporting period, and looked at the various S&P 500 components held by each of these reporting hedge funds and other 13F filers. For each component, we totaled the number of shares across across all of these funds. Next, we went back to the 09/30/2014 period, and went read »

A study of analyst recommendations at the major brokerages shows that FedEx Corp (NYSE: FDX) is the #50 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period. In forming read »

Sweet Briar College will close at the end of the academic year despite having a $94 million endowment. Ranked #245 on Forbes Best Colleges List, Sweet Briar’s closing shows that economic and enrollment strains are hitting even the best of the small liberal arts colleges hard. Who will be next? read »

For this quarter, we expect the company’s revenues to grow on a year-over-year basis on the back of strong demand for panels (the company has guided shipments of over 1 GW for the quarter), although margins could decline slightly owing to a smaller mix of project sales and a possibility of higher sales to China. During Q3, the company saw read »

We think the industry dynamics are clearly unfavorable for Zynga, as many of the Porter Five Forces indicate a high level of threat. Although already intense, the competitive rivalry within the industry could further intensify in the future due to the low barriers to entry in the mobile gaming business. Coupled with high bargaining power for read »

The crux is that the company is making some significant moves to expand in a market with strong growth potential. Cancer drugs have traditionally been much less effective as compared to drugs catering other therapeutic areas. Besides, there are numerous types and sub-types of cancer which warrant development of very specific drugs. These factors read »